Cell-Based Assays: World Industry and Market Prospects 2015-2025

セルベースアッセイの世界市場:セルベースアッセイ装置/消耗品/サービス

◆タイトル:Cell-Based Assays: World Industry and Market Prospects 2015-2025
◆商品コード:VGAIN5050808
◆調査・発行会社:visiongain
◆発行日:2015年4月
◆ページ数:170
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserGBP1,799 ⇒換算¥278,845見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥464,845見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥774,845見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、セルベースアッセイの世界市場について調査・分析し、以下の構成でお届けいたします。

・レポートの概要
・イントロダクション
・セルベースアッセイの世界市場
 (市場規模予測、市場の成長要因・阻害要因など)
・セルベースアッセイの世界市場:セグメント別市場分析
・地域別市場分析、市場規模予測
・技術動向、市場動向、市場展望
・市場環境分析
・専門家の見解
・主要企業分析
・結論

Cellular testing for pharmaceuticals – how to discover that technology’s commercial potential
What’s the future of technologies for screening cells? Now discover those technological and commercial predictions from 2015. Stay ahead there for data, benefiting your influence. For those medical tests, you explore sales results, R&D, opportunities and revenue forecasts.

That new report by visiongain shows you what’s possible for cell-based assays and related applications to aid drug discovery and development. Those R&D tools change pharma, opening new possibilities. Find out how, discovering predicted trends, progress and gains.

Use of cell lines in bioassays becomes more important. Read on, then, to explore cell assaying products and services for medicine, seeing how high their revenues can go.

Forecasts and other analysis showing potential revenues from those bioassays
That study’s purpose is forecasting cell testing sales to 2025 at overall world, submarket and national level. Does our work answer every question? No, though it assesses those technologies for research and development, showing there the money and potential gains.

There avoid struggles to find information on bioassays. Hear what’s possible. Besides revenue predictions, our new analysis shows recent results, growth rates and market shares.

The new survey gives you 63 tables, 40 charts and three interviews with companies. So help your research, analyses and decisions now, also benefiting your authority and reputation for technological and commercial insight.

And the following sections explain how that investigation helps your work.

Predictions for the cellular assays market and its segments – assess sales prospects
What potential does that biomedical industry hold? And what secrets underpin its progress? Discover in our report overall world revenue to 2025 for cell assays, with discussions.

Also find individual revenue predictions from 2015 for submarkets there, at world level:
• Products
• Services

And get further revenue breakdown, from 2015, by application:
• Drug discovery
• ADME (absorption, distribution, metabolism, excretion)
• Basic research.

There assess revenue expansion, hearing where you could gain. Those uses include toxicity testing. See what’s possible and investigate competition among developers and producers of cellular tests. You explore products, services, emerging technologies and rising sales.

That work also divides its overall world market into geographical revenue predictions.

Sales in leading national markets – what demand for medical cell assaying?
Our analyses also show you individual revenue forecasts to 2025 for 11 leading countries:
• United States (US)
• Japan
• Germany, France, United Kingdom (UK), Italy and Spain (EU5 countries), also with an overall European Union prediction
• Brazil, Russia, India and China (BRIC nations).

There you find countries with highest revenues, demand and potential increases in cell assay use and sales. And you understand competitors, needs and opportunities. That way you explore trends, progress and potentials, discovering what gains the future holds.

Also how do events, challenges and advances in technology affect that bioassays sector? Our study explains. It discusses progress, policies and trends influencing cellular assaying, helping you stay ahead in knowledge.

Forces affecting developers and producers of those drug discovery and development tools
The report explains issues, operations and events affecting that market from 2015. Those forces influencing companies developing, making and selling those systems include these:
• Uses in drug discovery, validating targets and lead profiling – including 2D and 3D bioassaying systems
• Platforms using high throughput screening (HTS) for improved testing efficiency
• Stem cells (inc. IPSCs) to extend molecular screening, esp. in toxicology studies, and other cell lines for pharma in vitro assays
• Systems using biochemical assays, GPCRs (G-protein-coupled receptors) and label-free methods
• Applications in developing biological drugs
• Contract and clinical research organisations (CROs) in that early-stage drug development.

And you explore these trends and influences, among others:
• Lead identification, target validation, primary, secondary and ADME screening
• Cell assaying equipment, kits, consumables and disposables
• Detection technology, microplate readers, microfluidics and flow cytometry, inc. assay miniaturisation and automation
• Multiplexing to improve efficiency in studying biological materials
• Cell viability and mitochondrial function assays in biomedical research
• High content screening (HCS) – optimising processes, increasing R&D pipeline efficiencies.

There you explore what progress, trends and prospects in those bioassays mean. And discover what benefits and what restricts participants in that industry, affecting its results.


Cell technologies for medical product development – top companies and 2018 market value
What does the future hold? Our study predicts that world market will reach $5.5bn in 2018.

Also, from 2015, outsourcing of cell-based assay processes will increase. There pharmaceutical clients and CROs will benefit. See how, discovering potentials.

And our new report examines activities of many companies, including these:
• Thermo Fisher Scientific
• PerkinElmer
• DiscoveRx
• GE Healthcare
• ProQinase
• Charles River Laboratories
• BD (Becton, Dickinson and Company).

There you find profiles of 18 prominent, rising and emerging companies. And see interviews with Cell Assay Innovations (CAI), Molecular Devices and CYTOO. Our survey explores issues affecting that industry’s present and future.

Cell and tissue-based screening holds great potential. From this decade onwards, that market gives many opportunities. See where they lie and how that industry can perform.

【レポートの目次】

1. Report Overview
1.1 Cell-Based Assays: Overview
1.2 Cell-Based Assays Market Segmentation
1.3 Why You Should Read This Report
1.4 How this Report Delivers
1.5 Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to Cell-Based Assays and Applications
2.1 Cost of New Drug Discovery and Development Reaches $2.6bn – Companies Constantly Looking for Increased Efficiencies
2.2 Drug Discovery Approaches- Target-Based and Phenotype-Based Discovery
2.3 Drug Screening Assays
2.4 Animal Models: In Vivo Conditions, but Results May Not Be Transferable to People
2.5 Biochemical Assays and their Advantages over Animal Models
2.5.1 Applications of Biochemical Assays
2.5.2 Lead Identification and Toxicity Testing
2.6 Cell-Based Assays and their Advantages
2.7 2D vs 3D Cell-Based Assays
2.8 The Different Assay Detection Methods and Technologies
2.9 Cells Used in Cell-Based Assays
2.9.1 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cells
2.9.2 Primary Cells: Closer to the In Vivo Environment, but Short Supply
2.9.3 Stem Cells: Potential to Overcome Limitations of Primary Cells and Immortalised Cell Lines
2.10 Uses for Cell-Based Assays in Drug Discovery and Development
2.10.1 Target Validation
2.10.2 Primary Screening
2.10.3 Secondary Screening
2.10.4 ADME Screening
2.10.5 High Throughput Screening: Greatly Increases Efficiency

3. World Cell-Based Assays Market, 2015-2025
3.1 Global Cell-Based Assays Market Forecast 2015-2025
3.2 Drivers for the Cell-Based Assays Market
3.3 Restraints for the Cell-Based Assays Market
3.4 Cell-Based Assays: Market Segments – Products and Services
3.5 Cell-Based Assays, Market Segments: Products Forecast 2015-2025
3.5.1 The Three Main Categories of Cell-Based Assay Products
3.5.1.1 Equipment Needed to Conduct Cell-Based Assays
3.5.1.2 Disposables Necessary to Perform Cell-Based Assays
3.5.1.3 Consumables Forming the Basis of Cell-Based Assays
3.6 Cell-Based Assays Market Segments: Services
3.6.1 Cell-Based Assays Market Segments: Services Forecast 2015-2025
3.7 Cell-Based Assays Market: Applications Forecasts 2015-2025
3.7.1 Drug Discovery Segment
3.7.2 ADME (Absorption, Distribution, Metabolism, Excretion) Segment
3.7.3 Basic Research Segment

4. Leading National Markets for Cell-Based Assays, 2015-2025
4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2014 and 2025
4.2 Global Cell-Based Assays Market: Regional Forecast 2015-2025
4.3 The US Cell-Based Assays Revenue Forecast to 2025
4.4 European Union (EU) Cell-Based Assays Market 2015-2025
4.4.1 IMI’s Pan-European Drug Discovery Platform Holds Much Promise
4.4.2 EU Market: National Breakdown, 2014 and 2025
4.4.3 EU Market: Main National Forecasts 2015-2025
4.4.4 German Cell-Based Assay Revenue Forecast to 2025
4.4.5 French Cell-Based Assays Revenue Forecast to 2025
4.4.6 UK Cell-Based Assays Revenue Forecast to 2025
4.4.7 Spanish Cell-Based Assays Revenue Forecast to 2025
4.4.8 Italian Cell-Based Assays Revenue Forecast to 2025
4.5 Japanese Cell-Based Assays Revenue Forecast to 2025
4.6 BRIC Nations (Brazil, Russia, India, China) Cell-Based Assays Market
4.6.1 BRIC Countries: National Breakdown 2014 and 2015
4.6.2 BRIC Countries: National Forecasts 2015-2025
4.6.3 Chinese Cell-Based Assay Revenue Forecast to 2025
4.6.4 Indian Cell-Based Assays Revenue Forecast to 2025
4.6.5 Russian Cell-Based Assays Revenue Forecast to 2025
4.6.6 Brazilian Cell-Based Assays Revenue Forecast to 2025

5. Companies in the Cell-Based Assays Market: Product Suppliers, 2015
5.1 Thermo Fisher Scientific
5.1.1 Cell-Based Assay Technologies under the Life Technologies Business Unit – Over 300 Products Offered
5.1.2 Also Offers Custom Assays, Related Products and HCA Products
5.2 DiscoveRx
5.2.1 PathHunter Technology
5.2.2 Other Assay Platforms and Drug Discovery Services
5.3 PerkinElmer
5.3.1 AlphaScreen Technology
5.3.2 DELFIA TRF Assays
5.3.3 Label-Free Cellular Assay Detection, and the Opera System
5.4 BD (Becton, Dickinson and Company)
5.4.1 Cell-Based Assays Through BD Life Sciences
5.5 InSphero
5.5.1 GravityPLUS- Leading Solution for 3D Cell-Based Assays
5.6 Biocroi
5.6.1 The Technology Behind and the Advantages of Happy Cell ASM and its 3D Cell Culture
5.7 GE Healthcare
5.7.1 Cell-Based Assays Through GE Healthcare Life Sciences
5.8 Molecular Devices
5.8.1 Cell-Based Assay Products Include SpectraMax Microplate Readers and FLIPR Tetra System
5.9 Promega
5.9.1 Assays Range from Cell Viability Assays to Mitochondrial Function Assays
5.10 BioVision
5.10.1 Cell-Based Assays Include the EZCell Platform and a Cholesterol Detection Kit

6. Companies in the Cell-Based Assays Market: CROs and Service Providers, 2015
6.1 Fluofarma
6.1.1 Over 100 Cell-Based Assays, and Partnership with Harlan
6.2 CYTOO
6.2.1 Cell Micropatterning to Eliminate Trade-Off between Quantity and Quality?
6.2.2 Cell-Based Assays for Muscular Atrophy / Hypertrophy and Anti-Cancer Drug Profiling
6.3 Cell Assay Innovations (CAI)
6.3.1 ClariCELL Technology
6.4 ProQinase
6.4.1 Various Cell-Based Assays for Characterising Anti-Cancer Compounds
6.5 Charles River Laboratories
6.5.1 PhenoFocus – Portfolio of over 100 Primary Cell-Based Assays
6.6 SGS
6.6.1 Offers a Range of Services, Including 3D Cell-Based Assays
6.7 Pharmaceutical Product Development (PPD)
6.8 Marin Biologic Laboratories

7. Cell-Based Assays Technology, Trends and Future Outlook
7.1 Stem Cells: Vast Potential
7.1.1 The Benefits of using Stem Cells in Cell-Based Assays
7.1.2 IPSCs: An Uncontroversial and Abundant Source
7.1.3 Companies Providing Stem Cell-Based Assays
7.2 Toxicity Testing: Important Field for Cell-Based Assays
7.3 3D Systems: The Advantages of these Next Generation Cell Systems
7.3.1 Complexity of 3D Systems is a Challenge, but More and More are Gradually Reaching the Market
7.4 Increasing Outsourcing of Cell-Based Assays
7.5 Label-Free Technology
7.6 GPCRs: A Common Drug and Drug Discovery Target
7.6.1 GPCRs in Cell-Based Assays
7.6.2 Allosteric GPCRs
7.7 Increasing Miniaturisation and Automation
7.7.1 Advantages of Miniaturisation
7.7.2 Advantages of Automation
7.8 Microfluidics- Set to be a Trend
7.8.1 Can Mimic the In Vivo Environment
7.8.2 The Potential and the Challenges
7.9 Multiplexing: Improves Efficiency of Cell-Based Assays
7.9.1 Advantages will Drive Growth
7.10 High Content Screening: A Well Established Tool
7.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
7.11 Cell-Based Assays in Biologics Development

8. Qualitative Analysis of the Cell-Based Assays Market, 2015
8.1 SWOT Analysis of the Cell-Based Assays Market
8.1.1 Strengths Within the Cell-Based Assays Market
8.1.2 Weaknesses Within the Cell-Based Assays Market
8.1.3 Opportunities for the Cell-Based Assays Market
8.1.4 Threats to the Cell-Based Assays Market
8.2 STEP Analysis of the Cell-Based Assays Market
8.2.1 Social Factors
8.2.2 Technological Factors
8.2.3 Economic Factors
8.2.4 Political Factors

9. Research Interviews
9.1 Interview with Luc Selig, Chief Business Officer at CYTOO
9.1.1 CYTOO’s Definition a Cell-Based Assay, and the Cell-Based Assay Market
9.1.2 The Advantages of CYTOO’s Products and Services
9.1.3 Thoughts on the Competition Within the Cell-Based Assays Market
9.1.4 Revenue Expectations, Company Focus and the Future of the Cell-Based Assay Market
9.1.5 On Challenges for the Industry and Cell-Based Assays vs Animal Models
9.2 Interview with Molecular Devices
9.2.1 Molecular Devices’ Definition of the Market
9.2.2 On Molecular Devices’ Most Well-Known Products, and their Advantages
9.2.3 On the Future of the Cell-Based Assays Market
9.2.4 Opportunities and Challenges for the Market, and the Competition Within it
9.3 Interview with Deborah Moshinsky, President and CEO of Cell Assay Innovations (CAI)
9.3.1 On the Challenges of Developing a Cell-Based Assay
9.3.2 On ClariCELL Technology and its Advantages
9.3.3 Competition in the Cell-Based Assays Market and Future Perspectives

10. Conclusions from the Research and Analysis
10.1 Growth Has Been Driven by Advantages of Cell-Based Assays
10.2 Current Status of the Market and its Growth Drivers
10.3 The Most Dominant National Markets and Emerging Countries
10.4 Future Trends and Technology

List of Tables
Table 2.1 Main Parameters Required in Drug Discovery and Development
Table 2.2 Selected Label-Free Detection Technologies Used for Cell-Based Assays, 2015
Table 2.3 Cell-Based Assays for HTS in Drug Screening, 2015
Table 3.1 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2019
Table 3.2 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2020-2025
Table 3.3 Cell-Based Assays Market Segment Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.4 Cell-Based Assays Market Segment Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.5 Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.6 Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.7 Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.8 Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.9 Cell-Based Assays Market Application Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.10 Cell-Based Assays Market Application Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.11 Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.12 Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.13 ADME Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.14 ADME Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 3.15 Basic Research Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 3.16 Basic Research Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2014
Table 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2025
Table 4.3 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2014-2019
Table 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2020-2025
Table 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2014-2019
Table 4.6 US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2020-2025
Table 4.7 EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2014-2019
Table 4.8 EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2020-2025
Table 4.9 EU Market Breakdown by Leading Nation: Revenues ($m), Market Shares (%), 2014
Table 4.10 EU Market Breakdown by Leading Nation: Revenues ($m), Market Shares (%), 2025
Table 4.11 EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.12 EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.13 German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.14 German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.15 French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.16 French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.17 UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.18 UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.19 Spanish Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.20 Spanish Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.21 Italian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.22 Italian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.23 Japanese Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.24 Japanese Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.25 BRIC Countries Breakdown by Nation: Revenues ($m), Market Shares (%), 2014
Table 4.26 BRIC Countries Breakdown by Nation: Revenues ($m), Market Shares (%), 2025
Table 4.27 BRIC National Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.28 BRIC National Forecasts: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.29 Chinese Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.30 Chinese Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.31 Indian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.32 Indian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.33 Russian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.34 Russian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 4.35 Brazilian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2014-2019
Table 4.36 Brazilian Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), CAGR (%), Market Share (%), 2020-2025
Table 5.1 Life Technologies Cell-Based Assay Technology Overview, 2015
Table 5.2 Life Technologies Cell-Based Assay Technology Overview, 2015 (continued)
Table 5.3 Thermo Fisher Scientific High Content Analysis Products
Table 5.4 Other DiscoveRx Assay Platforms, 2015
Table 5.5 GE Healthcare Life Sciences Cell-Based Assay Products, 2015
Table 6.1 ProQinase Cell-Based Assay Services, 2015
Table 7.1 Selected Companies with Involvement in Stem Cell-Based Assays, 2015
Table 7.2 Selected Companies Offering Label-Free Assay Systems, 2015

List of Figures
Figure 1.1 Cell-Based Assays Market Segmented by Application
Figure 1.2 Cell-Based Assays Market Segmented by Sector
Figure 2.1 Stages of Pre-Clinical Drug Development
Figure 3.1 Global Cell-Based Assays Market Forecast: Revenue ($m), 2014-2025
Figure 3.2 Drivers and Restraints for the Cell-Based Assays Market, 2015
Figure 3.3 Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2014-2025
Figure 3.4 Cell-Based Assays Market Segments: Products Forecast- Revenue ($m), 2014-2025
Figure 3.5 Cell-Based Assay Products Overview, 2015
Figure 3.6 Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), 2014-2025
Figure 3.7 Cell-Based Assays Market Application Forecasts: Revenue ($m), 2014-2025
Figure 3.8 Drug Discovery Segment Forecast: Revenue ($m), 2014-2025
Figure 3.9 ADME Segment Forecast: Revenue ($m), 2014-2025
Figure 3.10 Drug Discovery Segment Forecast: Revenue ($m), 2014-2025
Figure 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2014
Figure 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2025
Figure 4.3 Global Cell-Based Assays Market, Regional Forecast: Revenues ($m), 2014-2025
Figure 4.4 US Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.5 EU Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.6 EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2014
Figure 4.7 EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2025
Figure 4.8 EU Market, Top National Forecasts: Revenue ($m), 2014-2025
Figure 4.9 German Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.10 French Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.11 UK Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.12 Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.13 Italian Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.14 Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.15 BRIC Countries Breakdown by Nation: Revenues ($m), Market Shares (%), 2014
Figure 4.16 BRIC Countries Breakdown by Nation: Revenues ($m), Market Shares (%), 2025
Figure 4.17 BRIC Countries Breakdown by Nation: Revenues ($m), 2014-2025
Figure 4.18 Chinese Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.19 Indian Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.20 Russian Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 4.21 Brazilian Cell-Based Assays Market Forecast: Revenues ($m), 2014-2025
Figure 5.1 Thermo Fisher Revenue Breakdown by Business Unit: Revenue ($m), 2014
Figure 5.2 PerkinElmer Revenue Breakdown: Revenue ($m), 2014
Figure 5.3 BD Revenue Breakdown: Revenue ($m), 2014
Figure 6.1 Charles River Laboratories Revenue Breakdown: Revenue ($m), 2014
Figure 7.1 Strengths and Weaknesses of the Cell-Based Assay Market, 2015
Figure 7.2 Opportunities and Threats for the Cell-Based Assay Market, 2015

【掲載企業】

AstraZeneca
Axiogenesis
Bayer
BBC (British Broadcasting Corporation)
BD (Becton, Dickinson and Company)
BioCity
Biocroi
Biofocus
BioSeek
BioVision
BMG Labtech
CareFusion Corporation
Cell Assay Innovations (CAI)
Cellartis (Takara Bio)
Cellomics
Cellular Dynamics
Charles River Laboratories
Corning
Covance
CXR Biosciences
Cyprotex
CYTOO
Di Carlo Laboratory
DiscoveRx
Dr. Reddy’s Laboratories
ESI BIO (BioTime)
Eurostars
Evotec
Fisher Scientific
Fluofarma
ForteBio
Foundation Top Institute Pharma
GE Healthcare
GenCell
General Electric (GE)
Harlan Laboratories
Imagen Biotech
InSphero
Janssen
Japan Institute of Biomedical Research
Jubilant Biosys
Lead Discovery Centre GmbH
Life Technologies Corporation
Marin Biologic Laboratories
Maxcyte
Merck & Co.
Molecular Devices
OcellO
PerkinElmer
Pharmaceutical Product Development (PPD)
Pharmacyclics
PharmaTimes
Princeton University
Promega
ProQinase
Quintiles
ReNeuron
ReproCELL
Roche
Sanofi
Seahorse Bioscience
SGS (Société Générale de Surveillance)
Solvo
SRU Biosystems
Swiss Federal Institute of Technology
SymCel
Syncom
The European Lead Factory (ELF)
The Innovative Medicines Initiative (IMI)
The National Health Service (NHS)
The Netherlands Cancer Institute
The Scientist Magazine
Thermo Electron
Thermo Fisher Scientific
Trinity College, Dublin
Tufts Center for the Study of Drug Development
UCB (Union Chimique Belge)
UCLA (University of California, Los Angeles)
UK Department of Health
University of Kyoto
University of Oxford
University of Zurich
US Congress
US FDA
Vala Sciences
WuXi

【レポートのキーワード】

セルベースアッセイ装置、セルベースアッセイ消耗品、セルベースアッセイサービス、セルベースアッセイ用途、新薬開発、培養細胞

★調査レポート[セルベースアッセイの世界市場:セルベースアッセイ装置/消耗品/サービス] ( Cell-Based Assays: World Industry and Market Prospects 2015-2025 / VGAIN5050808) 販売に関する免責事項
[セルベースアッセイの世界市場:セルベースアッセイ装置/消耗品/サービス] ( Cell-Based Assays: World Industry and Market Prospects 2015-2025 / VGAIN5050808) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆